Serum PCSK9 in relation to coronary near-infrared spectroscopy-derived lipid core burden index and long-term cardiovascular outcome [ATHEROREMO-NIRS substudy].

27 August 2017 (17:06 - 17:24)
Organised by:
Congress Presentation Part of: PCSK9: Beyond lipid - lowering effects? Atherosclerosis ESC Premium Access ESC Congress 2017